arrow
F

Fabiola Carrara

istituto di ricerche farmacologiche mario negri irccs
H指数:23
被引数:2,564

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy

富尔扎尔塔单抗在利妥昔单抗耐药的原发性膜性肾病中的前瞻性队列研究

2026-03-120
OAAI
Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium

成人碘海醇血浆清除率测量协议标准化: 欧洲肾脏功能协会的共识文件

2024-10-013
OAAI
Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial

奥曲肽长效释放对常染色体显性多囊肾病患者托伐普坦的影响: 试点,随机,安慰剂对照,交叉试验

2023-02-019
OA
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial

肾小球阻力预测无明显肾病的2型糖尿病患者的长期GFR下降: DEMAND试验的纵向亚组分析

2021-10-143
PREAI
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial
2019-08-0144
PREAI
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial

奥曲肽-LAR治疗晚期常染色体显性多囊肾病 (ALADIN 2): 一项随机、双盲、安慰剂对照、多中心试验

2019-04-0550
OAAI
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial
2019-02-2219
PREAI
Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled Trial
2016-09-1576
OAAI
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4
2016-02-2238
OA
Estimated Glomerular Filtration Rate in Renal Transplantation: The Nephrologist in the Mist

肾移植中估计的肾小球滤过率: 薄雾中的肾病学家

2015-12-0133
OAAI
Measurement of glomerular filtration rate: Internal and external validations of the iohexol plasma clearance technique by HPLC

肾小球滤过率的测量: HPLC对碘海醇血浆清除技术的内部和外部验证

2014-03-0119
PREAI
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
LANCET
IF88.5
2013-11-01208
PREAI
The GFR and GFR decline cannot be accurately estimated in type 2 diabetics

无法准确估计2型糖尿病患者的GFR和GFR下降

2013-07-01132
OAAI